News Highlights: Top Company News of the Day

Chinese Takeover of Aixtron Collapses After U.S. Ban 
 

A Chinese takeover bid for Aixtron of Germany collapsed, a week after President Barack Obama blocked the deal on national-security grounds, according to a statement from the suitor.

 
Dell Technologies Revenue Rises on EMC Deal 
 

Dell Technologies said revenue rose in its latest quarter though its loss deepened, months after the megamerger of Dell and EMC was completed.

 
McDonald's to Move Non-U.S. Tax Base to the UK 
 

McDonald's said a large portion of its non-U.S. income would be taxed in the U.K., following a restructuring that shifts operations away from Luxembourg.

 
Home Builder Hovnanian Posts Disappointing Results 
 

Home builder Hovnanian Enterprises Inc., which has struggled under a massive debt load, said earnings declined in the latest period even though revenue rose, hurt by climbing expenses.

 
Losses Mount at Sears 
 

Sears Holdings reported a $748 million quarterly loss as revenue and gross margin fell, extending woes for the struggling retailer as it continues to explore ways to monetize its key brands.

 
Sovereign-Wealth Funds, Macquarie Buy Stake in U.K. Gas Business 
 

A consortium led by Australia's Macquarie Group and including sovereign-wealth funds from China and Qatar agreed to buy a majority stake in National Grid's U.K. gas-distribution business for about $4.56 billion.

 
Entergy Plans to Close Michigan Nuclear Plant in 2018 
 

Entergy said it intends to close the Palisades Nuclear Power Plant in Michigan in October of 2018, part of the company's efforts to reduce its merchant power fleet amid low prices in the wholesale market.

 
Credit Suisse Names New Head of Global Internet Investment Banking 
 

Credit Suisse Group announced internally Thursday that it has hired Robert Peck as its new head of global internet investment banking.

 
Switzerland Buys Back its Own Luxury Watches 
 

Switzerland is re-importing its luxury watches at an increasing rate, as the industry grapples with weaker global growth, slowdowns in parts of Asia and reduced tourism in Europe.

 
Horizon Pharma Shares Plunge on Failed Late-Stage Study 
 

Horizon Pharma shares slid 20% after a late-stage study for a genetic disease treatment broadly failed testing.

(END) Dow Jones Newswires

December 08, 2016 11:15 ET (16:15 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.